Bio-Rad Laboratories Gross Profit 2006-2019 | BIO.B

Bio-Rad Laboratories annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Bio-Rad Laboratories gross profit for the quarter ending June 30, 2019 was $0.308B, a 2.02% increase year-over-year.
  • Bio-Rad Laboratories gross profit for the twelve months ending June 30, 2019 was $1.239B, a 0.75% decline year-over-year.
  • Bio-Rad Laboratories annual gross profit for 2018 was $1.223B, a 2.98% increase from 2017.
  • Bio-Rad Laboratories annual gross profit for 2017 was $1.188B, a 4.33% increase from 2016.
  • Bio-Rad Laboratories annual gross profit for 2016 was $1.138B, a 1.49% increase from 2015.
Bio-Rad Laboratories Annual Gross Profit
(Millions of US $)
2018 $1,223
2017 $1,188
2016 $1,138
2015 $1,122
2014 $1,179
2013 $1,178
2012 $1,155
2011 $1,179
2010 $1,091
2009 $1,000
2008 $963
2007 $791
2006 $713
2005 $646
Bio-Rad Laboratories Quarterly Gross Profit
(Millions of US $)
Q2 2019 $308
Q1 2019 $312
Q4 2018 $333
Q3 2018 $287
Q2 2018 $302
Q1 2018 $302
Q4 2017 $345
Q3 2017 $299
Q2 2017 $273
Q1 2017 $270
Q4 2016 $315
Q3 2016 $279
Q2 2016 $280
Q1 2016 $264
Q4 2015 $309
Q3 2015 $263
Q2 2015 $280
Q1 2015 $270
Q4 2014 $317
Q3 2014 $289
Q2 2014 $297
Q1 2014 $275
Q4 2013 $323
Q3 2013 $284
Q2 2013 $300
Q1 2013 $271
Q4 2012 $315
Q3 2012 $274
Q2 2012 $288
Q1 2012 $279
Q4 2011 $312
Q3 2011 $296
Q2 2011 $293
Q1 2011 $278
Q4 2010 $300
Q3 2010 $266
Q2 2010 $268
Q1 2010 $257
Q4 2009 $268
Q3 2009 $261
Q2 2009 $242
Q1 2009 $229
Q4 2008 $247
Q3 2008 $241
Q2 2008 $248
Q1 2008 $227
Q4 2007 $234
Q3 2007 $188
Q2 2007 $190
Q1 2007 $179
Q4 2006 $186
Q3 2006 $167
Q2 2006 $185
Q1 2006 $176
Q4 2005 $163
Q3 2005 $157
Q2 2005 $161
Q1 2005 $166
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.647B $2.290B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.673B 13.86
Gilead Sciences (GILD) United States $81.699B 10.03
CSL (CSLLY) Australia $74.842B 0.00
Celgene (CELG) United States $71.151B 11.01
Illumina (ILMN) United States $45.616B 53.59
Vertex Pharmaceuticals (VRTX) United States $44.619B 48.22
Biogen (BIIB) United States $41.641B 7.40
Regeneron Pharmaceuticals (REGN) United States $33.547B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.723B 11.98
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.152B 0.00
Incyte (INCY) United States $16.659B 49.03
Seattle Genetics (SGEN) United States $13.329B 0.00
Exact Sciences (EXAS) United States $12.282B 0.00
Genmab (GNMSF) Denmark $12.097B 67.86
BioMarin Pharmaceutical (BMRN) United States $12.067B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.801B 0.00
Galapagos (GLPG) Belgium $8.558B 0.00
Bio-Techne Corp (TECH) United States $7.583B 52.38
Sarepta Therapeutics (SRPT) United States $6.371B 0.00
QIAGEN (QGEN) Netherlands $6.143B 20.18
Guardant Health (GH) United States $5.967B 0.00
BeiGene (BGNE) Cayman Islands $5.817B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.704B 0.00
Amarin (AMRN) Ireland $5.519B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.086B 12.93
Exelixis (EXEL) United States $4.962B 12.90
Bluebird Bio (BLUE) United States $4.907B 0.00
Moderna (MRNA) United States $4.599B 0.00
China Biologic Products (CBPO) China $4.526B 28.25
ARGENX SE-ADR (ARGX) Netherlands $4.253B 0.00
Medicines (MDCO) United States $4.141B 0.00
Ascendis Pharma (ASND) Denmark $3.986B 0.00
Repligen (RGEN) United States $3.981B 77.25
Spark Therapeutics (ONCE) United States $3.797B 0.00
Blueprint Medicines (BPMC) United States $3.534B 0.00
MorphoSys AG (MOR) Germany $3.402B 0.00
Reata Pharmaceuticals (RETA) United States $3.028B 0.00
Mirati Therapeutics (MRTX) United States $3.024B 0.00
Alkermes (ALKS) Ireland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.707B 40.67
Immunomedics (IMMU) United States $2.699B 0.00
Genomic Health (GHDX) United States $2.601B 48.78
Genmab (GMAB) Denmark $2.547B 0.00
MyoKardia (MYOK) United States $2.458B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.358B 5.07
Halozyme Therapeutics (HALO) United States $2.297B 0.00
RA PHARMCTL INC (RARX) United States $2.207B 0.00
Myriad Genetics (MYGN) United States $2.192B 23.01
Acceleron Pharma (XLRN) United States $2.121B 0.00
NeoGenomics (NEO) United States $2.046B 109.44
Amicus Therapeutics (FOLD) United States $2.022B 0.00
Cambrex (CBM) United States $2.010B 25.41
CRISPR Therapeutics AG (CRSP) Switzerland $2.005B 0.00
Ligand Pharmaceuticals (LGND) United States $1.991B 25.17
Intercept Pharmaceuticals (ICPT) United States $1.989B 0.00
Zai Lab (ZLAB) China $1.942B 0.00
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.586B 0.00
UniQure (QURE) Netherlands $1.586B 0.00
Insmed (INSM) United States $1.522B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.401B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.326B 0.00
REGENXBIO (RGNX) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.255B 0.00
Zymeworks (ZYME) Canada $1.101B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.093B 0.00
Innoviva (INVA) United States $1.084B 3.13
Alector (ALEC) United States $1.010B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.003B 0.00
Editas Medicine (EDIT) United States $0.982B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
Fate Therapeutics (FATE) United States $0.924B 0.00
AnaptysBio (ANAB) United States $0.916B 0.00
Epizyme (EPZM) United States $0.911B 0.00
ANI Pharmaceuticals (ANIP) United States $0.860B 14.36
Athenex (ATNX) United States $0.837B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.805B 0.00
Anika Therapeutics (ANIK) United States $0.785B 27.78
Pharming Group (PHGUF) Netherlands $0.782B 0.00
Codexis (CDXS) United States $0.777B 0.00
Cara Therapeutics (CARA) United States $0.755B 0.00
Twist Bioscience (TWST) United States $0.746B 0.00
Zealand Pharma (ZEAL) Denmark $0.738B 8.28
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
Principia Biopharma (PRNB) United States $0.705B 364.63
ZIOPHARM Oncology Inc (ZIOP) United States $0.697B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.689B 24.89
WAVE Life Sciences (WVE) Singapore $0.681B 0.00
Cytokineticsorporated (CYTK) United States $0.654B 0.00
Vericel (VCEL) United States $0.636B 0.00
Mesoblast (MESO) Australia $0.620B 0.00
Revance Therapeutics (RVNC) United States $0.618B 0.00
Heska (HSKA) United States $0.570B 73.87
Arvinas (ARVN) United States $0.562B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
MiMedx (MDXG) United States $0.550B 0.00
Intellia Therapeutics (NTLA) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.496B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.488B 0.00
PHARMA MAR SA (PHMMF) Spain $0.482B 0.00
Retrophin (RTRX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.430B 0.00
Intra-Cellular Therapies (ITCI) United States $0.429B 0.00
DBV Technologies S.A (DBVT) France $0.427B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.424B 0.00
Cellectis S.A (CLLS) France $0.413B 0.00
Adverum Biotechnologies (ADVM) United States $0.393B 0.00
Stemline Therapeutics (STML) United States $0.382B 0.00
Syros Pharmaceuticals (SYRS) United States $0.370B 0.00
Agenus (AGEN) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.368B 0.00
Arcus Biosciences (RCUS) United States $0.367B 0.00
Bellus Health (BLU) Canada $0.366B 0.00
Merus (MRUS) Netherlands $0.361B 0.00
Precision BioSciences (DTIL) United States $0.349B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.344B 0.00
Kadmon Holdings (KDMN) United States $0.337B 0.00
AC Immune SA (ACIU) Switzerland $0.335B 24.80
CytomX Therapeutics (CTMX) United States $0.320B 0.00
Prothena (PRTA) Ireland $0.311B 0.00
Gritstone Oncology (GRTS) United States $0.307B 0.00
Protagonist Therapeutics (PTGX) United States $0.300B 0.00
Avid Bioservices (CDMO) United States $0.298B 0.00
Theratechnologies (THTX) Canada $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
Geron (GERN) United States $0.275B 0.00
Cel-Sci (CVM) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.273B 0.00
PDL BioPharma (PDLI) United States $0.273B 7.03
Scholar Rock Holding (SRRK) United States $0.269B 0.00
Dynavax Technologies (DVAX) United States $0.266B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Puma Biotechnology (PBYI) United States $0.264B 0.00
MannKind (MNKD) United States $0.245B 0.00
Prometic Life Sciences (PFSCF) Canada $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.217B 0.00
Sutro Biopharma (STRO) United States $0.216B 0.00
Albireo Pharma (ALBO) United States $0.215B 0.00
Seres Therapeutics (MCRB) United States $0.214B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.212B 0.00
Inovio Pharmaceuticals (INO) United States $0.211B 0.00
Compugen (CGEN) Israel $0.206B 0.00
Sorrento Therapeutics (SRNE) United States $0.206B 0.00
Athersys (ATHX) United States $0.205B 0.00
Exicure (XCUR) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Kamada (KMDA) Israel $0.203B 7.77
Spero Therapeutics (SPRO) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.186B 5.45
ChromaDex (CDXC) United States $0.182B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Dyadic (DYAI) United States $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.173B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.172B 0.00
Clovis Oncology (CLVS) United States $0.171B 0.00
Affimed (AFMD) Germany $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.158B 0.00
XOMA (XOMA) United States $0.156B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Senesco Technologies (ELOX) United States $0.151B 0.00
Cerecor (CERC) United States $0.151B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
Arsanis (XFOR) United States $0.144B 0.00
BioTime (LCTX) United States $0.139B 9.30
Northwest Biotherapeutics (NWBO) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
CorMedix Inc (CRMD) United States $0.126B 0.00
NantKwest (NK) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Novavax (NVAX) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.107B 4.40
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Emmaus Life Sciences (EMMA) United States $0.107B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.107B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Celyad SA (CYAD) Belgium $0.098B 0.00
Aptinyx (APTX) United States $0.095B 0.00
OvaScience (MLND) United States $0.095B 0.00
Trevena (TRVN) United States $0.091B 0.00
VBI Vaccines (VBIV) United States $0.090B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Fortress Biotech (FBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.081B 0.00
ARAVIVE, INC (ARAV) United States $0.080B 0.00
Aduro Biotech (ADRO) United States $0.079B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Mersana Therapeutics (MRSN) United States $0.071B 0.00
Curis (CRIS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.058B 21.06
Catabasis Pharmaceuticals (CATB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
AquaBounty Technologies (AQB) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Unum Therapeutics (UMRX) United States $0.045B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
NewLink Genetics (NLNK) United States $0.044B 0.00
Stellar Biotechnologies (EDSA) Canada $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
VIVUS (VVUS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Proteostasis Therapeutics (PTI) United States $0.040B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.90
Clearside Biomedical (CLSD) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
DiaMedica Therapeutics (DMAC) United States $0.026B 0.00
Protalix BioTherapeutics (PLX) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
TrovaGene (TROV) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.003B 0.00